Cantor Fitzgerald restated their hold rating on shares of athenahealth, Inc. (NASDAQ:ATHN) in a report released on Friday, October 20th. They currently have a $145.00 price objective on the health services provider’s stock.
“After the close on Thursday, October 19, ATHN reported 3Q17 results with EPS above consensus expectations.”,” Cantor Fitzgerald’s analyst wrote.
ATHN has been the subject of a number of other research reports. Piper Jaffray Companies reiterated a buy rating and issued a $152.00 price objective on shares of athenahealth in a report on Friday, July 14th. Leerink Swann set a $155.00 price target on athenahealth and gave the stock a hold rating in a report on Thursday, October 19th. Oppenheimer Holdings, Inc. increased their price target on athenahealth from $154.00 to $184.00 and gave the stock an outperform rating in a report on Friday, July 21st. Wells Fargo & Company reaffirmed an outperform rating and set a $190.00 price objective (up from $130.00) on shares of athenahealth in a research report on Saturday, July 22nd. Finally, BidaskClub cut athenahealth from a hold rating to a sell rating in a research report on Tuesday, August 1st. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have given a buy rating to the company’s stock. athenahealth presently has an average rating of Hold and a consensus price target of $143.22.
Shares of athenahealth (NASDAQ ATHN) opened at 129.10 on Friday. The stock’s 50 day moving average is $123.99 and its 200 day moving average is $130.76. The stock has a market cap of $5.15 billion, a P/E ratio of 163.83 and a beta of 1.76. athenahealth has a 12 month low of $90.11 and a 12 month high of $158.66.
athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.06. The company had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.60 earnings per share. Analysts predict that athenahealth will post $2.02 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “athenahealth’s (NASDAQ:ATHN) “Hold” Rating Reiterated at Cantor Fitzgerald” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/10/29/athenahealth-inc-athn-earns-hold-rating-from-cantor-fitzgerald.html.
In related news, CEO Jonathan Bush sold 4,000 shares of the firm’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $143.31, for a total transaction of $573,240.00. Following the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at approximately $45,831,541.17. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $142.88, for a total value of $42,864.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 16,583 shares of company stock worth $2,236,924. 3.20% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC lifted its holdings in athenahealth by 0.8% during the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares during the period. Janus Henderson Group PLC acquired a new position in athenahealth during the 2nd quarter worth about $713,856,000. Vanguard Group Inc. lifted its holdings in athenahealth by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock worth $435,795,000 after buying an additional 53,361 shares during the period. Capital Research Global Investors lifted its holdings in athenahealth by 15.5% during the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock worth $286,963,000 after buying an additional 273,660 shares during the period. Finally, BlackRock Inc. lifted its holdings in athenahealth by 2.0% during the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock worth $229,377,000 after buying an additional 32,146 shares during the period.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.